{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T03:14:32Z","timestamp":1767237272803,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T00:00:00Z","timestamp":1513900800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00520-017-3997-9","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T09:00:39Z","timestamp":1513933239000},"page":"1881-1888","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Endovascular stent-based revascularization of malignant superior vena cava syndrome with concomitant implantation of a port device using a dual venous approach"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6669-4760","authenticated-orcid":false,"given":"Susanne","family":"Anton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Oechtering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Stahlberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kleemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Barkhausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Goltz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,22]]},"reference":[{"key":"3997_CR1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijscr.2015.06.017","volume":"13","author":"J Hamzika","year":"2015","unstructured":"Hamzika J, Chudejb J, Dziana A, Sokolb J, Kubisz P (2015) Endovascular stenting in malignant obstruction of superior vena cava. Int J Surg Case Rep 13:84\u201387. \n                    https:\/\/doi.org\/10.1016\/j.ijscr.2015.06.017","journal-title":"Int J Surg Case Rep"},{"issue":"1","key":"3997_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/01.md.0000198474.99876.f0","volume":"85","author":"TW Rice","year":"2006","unstructured":"Rice TW, Rodriguez RM, Light RW (2006) The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine 85(1):37\u201342. \n                    https:\/\/doi.org\/10.1097\/01.md.0000198474.99876.f0","journal-title":"Medicine"},{"issue":"6","key":"3997_CR3","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/0002-9343(81)90823-8","volume":"70","author":"DE Schraufnagel","year":"1981","unstructured":"Schraufnagel DE, Hill R, Leech JA, Pare JA (1981) Superior vena caval obstruction. Is it a medical emergency? Am J Med 70(6):1169\u20131174. \n                    https:\/\/doi.org\/10.1016\/0002-9343(81)90823-8","journal-title":"Am J Med"},{"issue":"5","key":"3997_CR4","first-page":"458","volume":"30","author":"S Duvnjak","year":"2011","unstructured":"Duvnjak S, Andersen PE (2011) Endovascular treatment of superior vena cava syndrome. Int Angiol 30(5):458\u2013461","journal-title":"Int Angiol"},{"issue":"2","key":"3997_CR5","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2214\/AJR.08.1904","volume":"193","author":"L Lanciego","year":"2009","unstructured":"Lanciego L, Pangua C, Chacon JI et al (2009) Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome. Am J Roentgenol 193(2):549\u2013558. \n                    https:\/\/doi.org\/10.2214\/AJR.08.1904","journal-title":"Am J Roentgenol"},{"issue":"1","key":"3997_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00270-011-0310-z","volume":"36","author":"D Fagedet","year":"2013","unstructured":"Fagedet D, Thony F, Timsit JF, Rodiere M, Monnin-Bares V, Ferretti GR, Vesin A, Moro-Sibilot D (2013) Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy. Cardiovasc Intervent Radiol 36(1):140\u2013149. \n                    https:\/\/doi.org\/10.1007\/s00270-011-0310-z","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"2","key":"3997_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0169-5002(03)00361-1","volume":"43","author":"A Urruticoechea","year":"2004","unstructured":"Urruticoechea A, Mesia R, Dominguez J et al (2004) Treatment of malignant superior vena cava syndrome by endovascular stent insertion. Experience on 52 patients with lung cancer. Lung Cancer 43(2):209\u2013214. \n                    https:\/\/doi.org\/10.1016\/S0169-5002(03)00361-1","journal-title":"Lung Cancer"},{"issue":"5","key":"3997_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1053\/clon.2002.0095","volume":"14","author":"NP Rowell","year":"2002","unstructured":"Rowell NP, Gleeson FV (2002) Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: a systematic review. Clin Oncol 14(5):338\u2013351. \n                    https:\/\/doi.org\/10.1053\/clon.2002.0095","journal-title":"Clin Oncol"},{"issue":"2","key":"3997_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00270-009-9699-z","volume":"33","author":"GA Krombach","year":"2010","unstructured":"Krombach GA, Plumhans C, Goerg F, G\u00fcnther RW (2010) Central vein dilatation prior to concomitant port implantation. Cardiovasc Intervent Radiol 33(2):362\u2013366. \n                    https:\/\/doi.org\/10.1007\/s00270-009-9699-z","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3997_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1055\/s-0042-122147","volume":"189","author":"FA B\u00fcstgens","year":"2017","unstructured":"B\u00fcstgens FA, Loose R, Ficker JH, Wucherer M, Uder M, Adamus M (2017) Stent implantation for superior vena cava syndrome of malignant cause. Fortschr R\u00f6ntgenstr 189:423\u2013430","journal-title":"Fortschr R\u00f6ntgenstr"},{"issue":"3","key":"3997_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2214\/ajr.177.3.1770585","volume":"177","author":"C Lanciego","year":"2001","unstructured":"Lanciego C, Chacon JL, Julian A et al (2001) Stenting as first option for endovascular treatment of malignant superior vena cava syndrome. Am J Roentgenol 177(3):585\u2013593. \n                    https:\/\/doi.org\/10.2214\/ajr.177.3.1770585","journal-title":"Am J Roentgenol"},{"issue":"4","key":"3997_CR12","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1177\/152660280301000416","volume":"10","author":"HP Dinkel","year":"2003","unstructured":"Dinkel HP, Mettke B, Schmid F, Baumgartner I, Triller J, Do DD (2003) Endovascular treatment of malignant superior vena cava syndrome: is bilateral wallstent placement superior to unilateral placement? J Endovasc Ther 10(4):788\u2013797. \n                    https:\/\/doi.org\/10.1177\/152660280301000416","journal-title":"J Endovasc Ther"},{"issue":"3","key":"3997_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jvir.2014.11.019","volume":"26","author":"T Mokry","year":"2015","unstructured":"Mokry T, Bellemann N, Sommer CM, Heussel CP, Bozorgmehr F, Gnutzmann D, Kortes NA, Kauczor HU, Radeleff B, Stampfl U (2015) Retrospective study in 23 patients of the self-expanding sinus-XL stent for treatment of malignant superior vena cava obstruction caused by non-small cell lung cancer. J Vasc Interv Radiol 26(3):357\u2013365. \n                    https:\/\/doi.org\/10.1016\/j.jvir.2014.11.019","journal-title":"J Vasc Interv Radiol"},{"key":"3997_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/01.RVI.0000094613.61428.a9","volume":"14","author":"D Sacks","year":"2003","unstructured":"Sacks D, Marinelli DL, Martin LG et al (2003) Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. J Vasc Interv Radiol 14:395\u2013404","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"3997_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2214\/ajr.148.2.259","volume":"148","author":"W Stanford","year":"1987","unstructured":"Stanford W, Jolles H, Stephen E, Chiu LC (1987) Superior vena cava obstruction: a venographic classification. AJR 148(2):259\u2013262. \n                    https:\/\/doi.org\/10.2214\/ajr.148.2.259","journal-title":"AJR"},{"key":"3997_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijscr.2015.06.017","volume":"13","author":"J Hamzik","year":"2015","unstructured":"Hamzik J, Chudej J, Dzian A, Sokol J, Kubisz P (2015) Endovascular stenting in malignant obstruction of superior vena cava. Int J Surg Case Rep 13:84\u201387. \n                    https:\/\/doi.org\/10.1016\/j.ijscr.2015.06.017","journal-title":"Int J Surg Case Rep"},{"key":"3997_CR17","unstructured":"Uberoi R, Patel R, Cox P et al (2015) CIRSE Quality assurance guidelines for superior vena cava stenting in malignant disease. \n                    https:\/\/eu-csite-storage-prod.s3.amazonaws.com\/www-cirse-org\/files\/files\/CIRSE_QA_Guidelines_for_SVC_Stenting_in_Malignant_Disease_Revision_Uberoi_2016.pdf\n                    \n                  . Accessed 28 May 2017"},{"key":"3997_CR18","first-page":"1","volume":"1","author":"S Duvnjak","year":"2011","unstructured":"Duvnjak S (2011) Malignant superior vena cava syndrome: endovascular stent treatment current status. J Palliat Care Med 1:1","journal-title":"J Palliat Care Med"},{"issue":"2","key":"3997_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ejrad.2008.04.014","volume":"71","author":"A Ganeshan","year":"2009","unstructured":"Ganeshan A, Hon LQ, Warakaulle DR, Morgan R, Uberoi R (2009) Superior vena caval stenting for SVC obstruction: current status. Eur J Radiol 71(2):343\u2013349. \n                    https:\/\/doi.org\/10.1016\/j.ejrad.2008.04.014","journal-title":"Eur J Radiol"},{"issue":"4","key":"3997_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.arbres.2013.10.009","volume":"50","author":"G Sobrinho","year":"2014","unstructured":"Sobrinho G, Aguiar P (2014) Stent placement for the treatment of malignant superior vena cava syndrome\u2014a single-center series of 56 patients. Arch Bronconeumol 50(4):135\u2013140. \n                    https:\/\/doi.org\/10.1016\/j.arbres.2013.10.009","journal-title":"Arch Bronconeumol"},{"issue":"4","key":"3997_CR21","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00330-002-1489-9","volume":"13","author":"MA Gregorio Ariza De","year":"2003","unstructured":"De Gregorio Ariza MA, Gamboa P, Gimeno MJ et al (2003) Percutaneous treatment of superior vena cava syndrome using metallic stent. Eur Radiol 13(4):853\u2013862. \n                    https:\/\/doi.org\/10.1007\/s00330-002-1489-9","journal-title":"Eur Radiol"},{"issue":"2","key":"3997_CR22","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jvs.2007.09.071","volume":"47","author":"AZ Rizvi","year":"2008","unstructured":"Rizvi AZ, Kalra M, Bjarnason H, Bower TC, Schleck C, Gloviczki P (2008) Benign superior vena cava syndrome: stenting is now the first line of treatment. J Vasc Surg 47(2):372\u2013380. \n                    https:\/\/doi.org\/10.1016\/j.jvs.2007.09.071","journal-title":"J Vasc Surg"},{"issue":"1","key":"3997_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00330-016-4354-y","volume":"27","author":"S Breault","year":"2017","unstructured":"Breault S, Doenz F, Jouannic AM, Qanadli SD (2017) Percutaneous endovascular management of chronic superior vena cava syndrome of benign causes: long-term follow-up. Eur Radiol 27(1):97\u2013104. \n                    https:\/\/doi.org\/10.1007\/s00330-016-4354-y","journal-title":"Eur Radiol"},{"issue":"1","key":"3997_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1148\/radiology.217.1.r00oc2789","volume":"217","author":"SO Trerotola","year":"2000","unstructured":"Trerotola SO, Kuhn-Fulton J, Johnson MS, Shah H, Ambrosius WT, Kneebone PH (2000) Tunneled infusion catheters: increased incidence of symptomatic venous thrombosis after subclavian versus internal jugular venous access. Radiology 217(1):89\u201393. \n                    https:\/\/doi.org\/10.1148\/radiology.217.1.r00oc2789","journal-title":"Radiology"},{"issue":"1","key":"3997_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s003300050027","volume":"10","author":"Y Takeuchi","year":"2000","unstructured":"Takeuchi Y, Arai Y, Kasahara T, Inaba Y, Shindo J, Kumada T (2000) Technical aspects of venous stenting in high-grade stenoses using a long guidewire between dual venous access sites. Eur Radiol 10(1):167\u2013169. \n                    https:\/\/doi.org\/10.1007\/s003300050027","journal-title":"Eur Radiol"},{"issue":"5","key":"3997_CR26","doi-asserted-by":"publisher","first-page":"434","DOI":"10.5301\/jva.5000402","volume":"16","author":"J Tonak","year":"2015","unstructured":"Tonak J, Fetscher S, Barkhausen J, Goltz JP (2015) Endovascular recanalization of a port catheter-associated superior vena cava syndrome. J Vasc Access 16(5):434\u2013436. \n                    https:\/\/doi.org\/10.5301\/jva.5000402","journal-title":"J Vasc Access"},{"issue":"5","key":"3997_CR27","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00270-014-0902-5","volume":"37","author":"F Thony","year":"2014","unstructured":"Thony F, Fagedet D, Michoud M, Moro-Sibilot D, Ferretti GR, Rodi\u00e8re M (2014) Anticoagulation is not mandatory after stenting for malignant superior vena cava syndrome. Cardiovasc Intervent Radiol 37(5):1403\u20131404. \n                    https:\/\/doi.org\/10.1007\/s00270-014-0902-5","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3997_CR28","unstructured":"Steinberger JD, Schenning RC (2015) Endovascular reconstruction of malignant IVC and SVC obstruction. IO:111\u2013113"},{"issue":"5","key":"3997_CR29","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00270-007-9088-4","volume":"30","author":"T Nagata","year":"2007","unstructured":"Nagata T, Makutani S, Uchida H, Kichikawa K, Maeda M, Yoshioka T, Anai H, Sakaguchi H, Yoshimura H (2007) Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava. Cardiovasc Intervent Radiol 30(5):959\u2013967. \n                    https:\/\/doi.org\/10.1007\/s00270-007-9088-4","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"3997_CR30","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2214\/AJR.12.9582","volume":"201","author":"G Maleux","year":"2013","unstructured":"Maleux G, Gillardin P, Fieuws S, Heye S, Vaninbroukx J, Nackaerts K (2013) Large-bore nitinol stents for malignant superior vena cava syndrome: factors influencing outcome. AJR Am J Roentgenol 201(3):667\u2013674. \n                    https:\/\/doi.org\/10.2214\/AJR.12.9582","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"3997_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/1538574416639149","volume":"50","author":"P Quaretti","year":"2016","unstructured":"Quaretti P, Galli F, Moramarco LP, Corti R, Leati G, Fiorina I, Tinelli C, Montagna G, Maestri M (2016) Stent grafts provided superior primary patency for central venous stenosis treatment in comparison with angioplasty and bare metal stent: a retrospective single center study on 70 hemodialysis patients. Vasc Endovasc Surg 50(4):221\u2013230. \n                    https:\/\/doi.org\/10.1177\/1538574416639149","journal-title":"Vasc Endovasc Surg"},{"issue":"3","key":"3997_CR32","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1148\/radiol.12120517","volume":"266","author":"DI Gwon","year":"2013","unstructured":"Gwon DI, Ko GY, Kim JH, Shin JH, Yoon HK, Sung KB (2013) Malignant superior vena cava syndrome: a comparative cohort study of treatment with covered stents versus uncovered stents. Radiology 266(3):979\u2013987. \n                    https:\/\/doi.org\/10.1148\/radiol.12120517","journal-title":"Radiology"},{"issue":"4","key":"3997_CR33","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jvir.2016.12.1222","volume":"28","author":"K Clark","year":"2017","unstructured":"Clark K, Beecham Chick JF, Reddy SN et al (2017) Concurrent central venous stent and central venous access device placement does not compromise stent patency or catheter function in patients with malignant central venous obstruction. J Vasc Interv Radiol 28(4):602\u2013607. \n                    https:\/\/doi.org\/10.1016\/j.jvir.2016.12.1222","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"3997_CR34","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0741-5214(99)70275-2","volume":"29","author":"RA El-Sabrout","year":"1999","unstructured":"El-Sabrout RA, Duncan JM (1999) Right atrial bypass grafting for central venous obstruction associated with dialysis access: another treatment option. J Vasc Surg 29(3):472\u2013478. \n                    https:\/\/doi.org\/10.1016\/S0741-5214(99)70275-2","journal-title":"J Vasc Surg"},{"issue":"6","key":"3997_CR35","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3109\/02841859809175494","volume":"39","author":"N Tanigawa","year":"1998","unstructured":"Tanigawa N, Sawada S, Mishima K, Okuda Y, Mizukawa K, Ohmura N, Toita T, Ogawa K, Kobayashi M, Kobayashi M (1998) Clinical outcome of stenting in superior vena cava syndrome associated with malignant tumours. Comparison with conventional treatment. Acta Radiol 39(6):669\u2013674. \n                    https:\/\/doi.org\/10.3109\/02841859809175494","journal-title":"Acta Radiol"},{"issue":"2","key":"3997_CR36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/thx.2007.086017","volume":"64","author":"N Nguyen","year":"2009","unstructured":"Nguyen N, Borok TL, Welsh J, Vinh-Hung V (2009) Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome. Thorax 64(2):174\u2013178. \n                    https:\/\/doi.org\/10.1136\/thx.2007.086017","journal-title":"Thorax"},{"issue":"5","key":"3997_CR37","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s003300050777","volume":"9","author":"F Thony","year":"1999","unstructured":"Thony F, Moro D, Witmeyer P, Angiolini S, Brambilla C, Coulomb M, Ferretti G (1999) Endovascular treatment of superior vena cava obstruction in patients with malignancies. Eur Radiol 9(5):965\u2013971. \n                    https:\/\/doi.org\/10.1007\/s003300050777","journal-title":"Eur Radiol"},{"issue":"1","key":"3997_CR38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejvs.2012.03.010","volume":"44","author":"C.-Y. Wu","year":"2012","unstructured":"Wu CY, Fu JY, Feng PH et al (2012) Risk factors and possible mechanisms of intravenous port catheter migration. Eur J Vasc Endovasc Surg 44:82\u201387","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"issue":"4","key":"3997_CR39","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00270-011-0271-2","volume":"35","author":"EM Walser","year":"2012","unstructured":"Walser EM (2012) Venous access ports: indications, implantation technique, follow-up, and complications. Cardiovasc Intervent Radiol 35(4):751\u2013764. \n                    https:\/\/doi.org\/10.1007\/s00270-011-0271-2","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3997_CR40","first-page":"877","volume":"56","author":"PE Andersen","year":"2015","unstructured":"Andersen PE, Midtgaard A, Brenoe AS, Elle B, Duvnjak S (2015) A new nitinol stent for use in superior cava syndrome. Initial clinical experience. J Cardiovasc Surg 56:877\u2013881","journal-title":"J Cardiovasc Surg"},{"issue":"3","key":"3997_CR41","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00270-008-9443-0","volume":"32","author":"MJ Ploegmakers","year":"2009","unstructured":"Ploegmakers MJ, Rutten MJ (2009) Fatal pericardial tamponade after superior vena cava stenting. Cardiovasc Intervent Radiol 32(3):585\u2013589. \n                    https:\/\/doi.org\/10.1007\/s00270-008-9443-0","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"3997_CR42","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00270-005-0284-9","volume":"29","author":"R Uberoi","year":"2006","unstructured":"Uberoi R (2006) Quality assurance guidelines for superior vena cava stenting in malignant disease. Cardiovasc Intervent Radiol 29(3):319\u2013322. \n                    https:\/\/doi.org\/10.1007\/s00270-005-0284-9","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-017-3997-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3997-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3997-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T04:53:52Z","timestamp":1568696032000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-017-3997-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,22]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["3997"],"URL":"https:\/\/doi.org\/10.1007\/s00520-017-3997-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2017,12,22]]},"assertion":[{"value":"23 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Local ethical committee approval was granted (File number 17-044A). This article does not contain any studies with animals performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}